(Q39420627)

11 September 2017

title

MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. (English)

1 reference

11 September 2017

Xie-Feng Wang

1

1 reference

11 September 2017

Zhu-Mei Shi

2

1 reference

11 September 2017

Xi-Rui Wang

3

1 reference

11 September 2017

Lei Cao

4

1 reference

11 September 2017

Ying-Yi Wang

5

1 reference

11 September 2017

Jun-Xia Zhang

6

1 reference

11 September 2017

Yu Yin

7

1 reference

11 September 2017

Hui Luo

8

1 reference

11 September 2017

Chun-Sheng Kang

9

1 reference

11 September 2017

Ning Liu

10

1 reference

11 September 2017

Tao Jiang

11

1 reference

11 September 2017

Yong-Ping You

12

1 reference

11 September 2017

language of work or name

1 reference

30 December 2011

1 reference

Journal of Cancer Research and Clinical Oncology

11 September 2017

published in

1 reference

11 September 2017

volume

138

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

573-584

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-011-1114-x

11 September 2017

exact match

0 references

cites work

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Ral GTPases and cancer: linchpin support of the tumorigenic platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNAs modulate hematopoietic lineage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Human glioma growth is controlled by microRNA-10b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

The cellular functions of small GTP-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

A transforming Kirsten ras oncogene in an oral squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

The prognostic influence of bcl-2 in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Hyperactive Ras in developmental disorders and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

The molecular biology of oral carcinogenesis: toward a tumor progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Bcl-2 family proteins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1114-X

Response and determinants of cancer cell susceptibility to PI3K inhibitors: combined targeting of PI3K and Mek1 as an effective anticancer strategy

21 January 2018

1 reference

12 December 2020

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1

1 reference

12 December 2020

MicroRNAs as oncogenes and tumor suppressors

1 reference

12 December 2020

Tumor-suppressive pathways in pancreatic carcinoma.

1 reference

12 December 2020

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

1 reference

12 December 2020

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient

1 reference

12 December 2020

Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin

1 reference

12 December 2020

10.1007/S00432-011-1114-X

Identifiers

DOI

1 reference

release_ggkrsmx4ojacrdueag6rkm2gri

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ggkrsmx4ojacrdueag6rkm2gri

24 November 2022

mapped directly with Wikidata item

1 reference